Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on April 19, 2025

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

Zacks

2 days ago

What Analyst Projections for Key Metrics Reveal About ResMed (RMD) Q3 Earnings

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

3 days ago

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

MT Newswires

3 days ago

Mizuho Securities Adjusts ResMed Price Target to $265 From $280, Maintains Outperform Rating

Argus Research

3 days ago

RMD: Rating decreased to a HOLD

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

4 days ago

Here's Why ResMed (RMD) is a Strong Growth Stock

MT Newswires

9 days ago

Baird Cuts Price Target on ResMed to $252 From $286, Maintains Outperform Rating

MT Newswires

10 days ago

ResMed's Fiscal Q3 Likely to Meet Consensus Estimates; Faces Supply Chain Risks, UBS Says

Morningstar Research

10 days ago

Analyst Report: ResMed Inc.

Argus Research

10 days ago

RMD: Lowering target price to $241.00

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Zacks

11 days ago

Strength Seen in ResMed (RMD): Can Its 3.8% Jump Turn into More Strength?

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

StockStory

11 days ago

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

Simply Wall St.

16 days ago

ResMed (NYSE:RMD) Launches NightOwl Device to Simplify Home Sleep Apnea Testing Across US

ResMed Inc. (RMD): A Bull Case Theory

Insider Monkey

16 days ago

ResMed Inc. (RMD): A Bull Case Theory

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

GlobeNewswire

16 days ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Insider Monkey

16 days ago

Resmed Inc. (RMD): Jim Cramer Says He Likes This Sleep Apnea Treatment Stock

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

GlobeNewswire

16 days ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Argus Research

17 days ago

RMD: Rating increased to a BUY

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

TipRanks

22 days ago

Morgan Stanley Sees Near-Term Rally Ahead — Here Are 2 Stocks to Bet on It

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Insider Monkey

24 days ago

Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well”

Argus Research

24 days ago

RMD: Raising target price to $232.00

ResMed initiated with an Overweight at Morgan Stanley

TipRanks

a month ago

ResMed initiated with an Overweight at Morgan Stanley

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

GlobeNewswire

a month ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

New Product Launches Benefit GMED Stock Amid Macro Issues

Zacks

a month ago

New Product Launches Benefit GMED Stock Amid Macro Issues

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

a month ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

Zacks

a month ago

The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

a month ago

NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus

Zacks

a month ago

RMD Stock Likely to Benefit From the New Brand Evolution Strategy

MT Newswires

a month ago

Resmed Consolidating Brands, Product Lines Under Single Name

GlobeNewswire

a month ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

StockStory

a month ago

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

Investor's Business Daily

a month ago

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

VEEV Stock Gains Following Latest Availability of HCP Access Data

Zacks

a month ago

VEEV Stock Gains Following Latest Availability of HCP Access Data

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks

a month ago

Is it Worth Adding ResMed Stock to Your Portfolio Now?

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

Zacks

a month ago

Zacks.com featured highlights include Taiwan, Tapestry, ABM Industries, Vertiv and ResMed

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

Zacks

a month ago

5 Best Dividend Growth Stocks to Buy Amid Trade War Fears

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

Zacks

a month ago

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

MT Newswires

a month ago

Stifel Adjusts Price Target on ResMed to $240 From $250, Maintains Hold Rating

Argus Research

a month ago

RMD: Lowering target price to $243.00

VEEV Stock Falls Despite Latest Announcement to Enable AI Innovation

Zacks

2 months ago

VEEV Stock Falls Despite Latest Announcement to Enable AI Innovation

2 Reasons to Like RMD and 1 to Stay Skeptical

StockStory

2 months ago

2 Reasons to Like RMD and 1 to Stay Skeptical

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

Zacks

2 months ago

Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

Zacks

2 months ago

AMED Q4 Earnings and Revenues Miss, Margins Dip, Stock Rises

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

Zacks

2 months ago

TransMedics Stock Rises as Q4 Earnings & Revenues Beat Estimates

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands

Zacks

2 months ago

OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands

Teleflex Stock Rises on Q4 Earnings Beat, Gross Margin Crashes

Zacks

2 months ago

Teleflex Stock Rises on Q4 Earnings Beat, Gross Margin Crashes

Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract

Zacks

2 months ago

Chemed Q4 Earnings & Revenues Top, Stock Climbs, Margins Contract

ResMed (NYSE:RMD) shareholders have earned a 7.2% CAGR over the last five years

Simply Wall St.

2 months ago

ResMed (NYSE:RMD) shareholders have earned a 7.2% CAGR over the last five years

AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract

Zacks

2 months ago

AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

Zacks

2 months ago

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

EYE Q4 Loss Narrower Than Expected, Margins Rise, Stock Surges

Zacks

2 months ago

EYE Q4 Loss Narrower Than Expected, Margins Rise, Stock Surges

MMSI Stock Gains in Pre-Market Post Q4 Earnings Beat, Margins Up

Zacks

2 months ago

MMSI Stock Gains in Pre-Market Post Q4 Earnings Beat, Margins Up

MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts

Zacks

2 months ago

MASI Stock Gains Following Q4 Earnings Beat, Gross Margin Contracts

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

2 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours

Zacks

2 months ago

Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

GlobeNewswire

2 months ago

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Argus Research

2 months ago

RMD: Raising target price to $248.00

HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket

Zacks

2 months ago

HSIC Q4 Earnings Match Estimates, Margins Up, Stock Falls in Premarket

HIMS Stock Declines Following Q4 Earnings Miss, Gross Margin Contracts

Zacks

2 months ago

HIMS Stock Declines Following Q4 Earnings Miss, Gross Margin Contracts

MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down

Zacks

2 months ago

MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

Zacks

2 months ago

Veracyte Stock Falls Despite Q4 Earnings and Revenue Beat

ILMN Stock Might Rise From Collaboration With Broad Clinical Labs

Zacks

2 months ago

ILMN Stock Might Rise From Collaboration With Broad Clinical Labs

ResMed Inc. (NYSE:RMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Simply Wall St.

2 months ago

ResMed Inc. (NYSE:RMD) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

AMN Stock Gains Following Q4 Earnings & Revenues Beat, Margins Down

Zacks

2 months ago

AMN Stock Gains Following Q4 Earnings & Revenues Beat, Margins Down

ITGR Stock Declines Following Q4 Earnings Miss, Gross Margin Contract

Zacks

2 months ago

ITGR Stock Declines Following Q4 Earnings Miss, Gross Margin Contract

PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise

Zacks

2 months ago

PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise

Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips

Zacks

2 months ago

Globus Medical Q4 Earnings & Revenues Top, Margins Expand, Stock Dips

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

Zacks

2 months ago

3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)

ICLR Q4 Earnings and Revenues Beat, Stock Rises at After-Market

Zacks

2 months ago

ICLR Q4 Earnings and Revenues Beat, Stock Rises at After-Market

EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y

Zacks

2 months ago

EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y

CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall

Zacks

2 months ago

CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall

Insulet Earnings: What To Look For From PODD

StockStory

2 months ago

Insulet Earnings: What To Look For From PODD

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

2 months ago

iRhythm (IRTC) To Report Earnings Tomorrow: Here Is What To Expect

Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises

Zacks

2 months ago

Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises

Argus Research

2 months ago

RMD: Lowering target price to $242.00

Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles

Zacks

2 months ago

Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles

BIO Stock Might Rise Following the Offer to Acquire Stilla

Zacks

2 months ago

BIO Stock Might Rise Following the Offer to Acquire Stilla

Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 26%?

Simply Wall St.

2 months ago

Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 26%?

BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket

Zacks

2 months ago

BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket

PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall

Zacks

2 months ago

PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall

DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand

Zacks

2 months ago

DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand

Here's Why ResMed (RMD) Could be Great Choice for a Bottom Fisher

Zacks

2 months ago

Here's Why ResMed (RMD) Could be Great Choice for a Bottom Fisher

Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls

Zacks

2 months ago

Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls

WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down

Zacks

2 months ago

WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down

QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract

Zacks

2 months ago

QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract

CVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise

Zacks

2 months ago

CVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise

DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

2 months ago

DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect

EW Stock Up on Q4 Earnings and Revenue Beat, Margins Crash

Zacks

2 months ago

EW Stock Up on Q4 Earnings and Revenue Beat, Margins Crash

ECL Stock Up in Pre-Market Following Q4 Earnings Beat, Margins Expand

Zacks

2 months ago

ECL Stock Up in Pre-Market Following Q4 Earnings Beat, Margins Expand

INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts

Zacks

2 months ago

INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts

MYGN Stock Might Rise on Collaboration With CancerCARE

Zacks

2 months ago

MYGN Stock Might Rise on Collaboration With CancerCARE

ResMed Close To Joining Very Elite Stock Group

Investor's Business Daily

2 months ago

ResMed Close To Joining Very Elite Stock Group

Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand

Zacks

2 months ago

Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats

Zacks

2 months ago

Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats

NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes

Zacks

2 months ago

NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes

Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises

Zacks

2 months ago

Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises

With 69% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing

Simply Wall St.

2 months ago

With 69% ownership, ResMed Inc. (NYSE:RMD) boasts of strong institutional backing

PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%

Zacks

2 months ago

PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8%

HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket

Zacks

2 months ago

HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket

QIAGEN Q4 Earnings Miss, Stock Crashes, Margins Expand

Zacks

2 months ago

QIAGEN Q4 Earnings Miss, Stock Crashes, Margins Expand

Share on Social Networks: